Health and Healthcare

Regeneron : REGN

All Regeneron Articles

244 Articles

Lee Jackson | Jun 1, 2018 at 10:30 AM EDT

Biotech and Pharmaceutical Giants Go All In With Big Data Analytics

It’s no surprise that it was only a matter of time before the usage and storage of big data and…

Chris Lange | May 11, 2018 at 4:08 PM EDT

Friday’s Biggest Winners and Losers in the S&P 500

Friday was a relatively positive day for the broad U.S. markets. Although crude oil backed off, it is still holding…

Jon C. Ogg | May 1, 2018 at 12:15 PM EDT

Will a PCSK9 Inhibitor Price Cut Help Drive Lowering LDL-Cholesterol Drug Use?

Regeneron Pharmaceuticals and Sanofi are committing to lowering the price of the anti-cholesterol drug Praluent.

Jon C. Ogg | Apr 17, 2018 at 11:35 AM EDT

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Rheumatoid arthritis is an autoimmune disease that attacks tissues within the joints, and it is a major target of U.S.…

Jon C. Ogg | Apr 9, 2018 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Alcoa, Cemex, Comerica, Facebook, GM, Incyte, Proofpoint, Regeneron and More

The top analyst upgrades, downgrades and other research calls from Monday include Alcoa, CEMEX, Comerica, Facebook, General Motors, Incyte, Proofpoint…

Lee Jackson | Mar 1, 2018 at 8:10 AM EST

10 Large Cap Stocks the Top Hedge Funds Are Buying Now

While chasing what portfolio managers own isn’t always the best idea, many people have made a lot of money by…

Jon C. Ogg | Feb 21, 2018 at 9:14 AM EST

Top Analyst Upgrades and Downgrades: Capital One, Domino’s, Home Depot, Mosaic, Regenron, Six Flags, US Steel, Walmart and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Capital One, Domino's, Home Depot, Mosaic, Regenron, Six…

Jon C. Ogg | Dec 28, 2017 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Amex, Cellectis, ForeScout, Mastercard, Mueller Water, PG&E, Party City, Regeneron, Visa and More

The include American Express, Cellectis, ForeScout Technologies, Mastercard, Mueller Water, PG&E, Party City, Regeneron Pharmaceuticals and Visa.

Lee Jackson | Dec 11, 2017 at 9:50 AM EST

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

One industry that could be a huge winner from tax reform, and may surprise some investors, is biotechnology, especially for…

Jon C. Ogg | Dec 6, 2017 at 10:05 AM EST

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately,…

Jon C. Ogg | Oct 20, 2017 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Baidu, Barclays, Celgene, HPE, Intel, Kimberly-Clark, Lululemon, PayPal, Stratasys and More

The top analyst upgrades, downgrades and other research calls from Friday include Baidu, Barclays, Celgene, HPE, Intel, Kimberly-Clark, Lululemon, PayPal…

Lee Jackson | Sep 21, 2017 at 8:30 AM EDT

4 Red-Hot Merrill Lynch US 1 Momentum Stocks to Buy for the Rest of 2017

24/7 Wall St. screened the Merrill Lynch US 1 list for the companies that have exhibited strong price momentum and…

Jon C. Ogg | Sep 13, 2017 at 7:15 AM EDT

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown…

Jon C. Ogg | Aug 11, 2017 at 7:35 AM EDT

10 Top Stocks Analysts Want You to Sell Now

Investors often hear when to buy a stock, but rarely when to sell. So far in August at least 10 key…

Jon C. Ogg | Jul 19, 2017 at 9:15 AM EDT

Top Analyst Upgrades & Downgrades: Boeing, Chipotle, First Solar, Goldman Sachs, IBM, Lockheed Martin, Lululemon, Vertex and Many More

Stocks were indicated to open only slightly higher on Wednesday after a mixed bag of corporate earnings. What investors need…

1 … 6 7 8 9 10 … 17

Regeneron : REGN

All Regeneron Articles

Biotech and Pharmaceutical Giants Go All In With Big Data Analytics

Friday’s Biggest Winners and Losers in the S&P 500

Will a PCSK9 Inhibitor Price Cut Help Drive Lowering LDL-Cholesterol Drug Use?

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Top Analyst Upgrades and Downgrades: Alcoa, Cemex, Comerica, Facebook, GM, Incyte, Proofpoint, Regeneron and More

10 Large Cap Stocks the Top Hedge Funds Are Buying Now

Top Analyst Upgrades and Downgrades: Capital One, Domino’s, Home Depot, Mosaic, Regenron, Six Flags, US Steel, Walmart and More

Top Analyst Upgrades and Downgrades: Amex, Cellectis, ForeScout, Mastercard, Mueller Water, PG&E, Party City, Regeneron, Visa and More

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Top Analyst Upgrades and Downgrades: Baidu, Barclays, Celgene, HPE, Intel, Kimberly-Clark, Lululemon, PayPal, Stratasys and More

4 Red-Hot Merrill Lynch US 1 Momentum Stocks to Buy for the Rest of 2017

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

10 Top Stocks Analysts Want You to Sell Now

Top Analyst Upgrades & Downgrades: Boeing, Chipotle, First Solar, Goldman Sachs, IBM, Lockheed Martin, Lululemon, Vertex and Many More

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

Regeneron : REGN

All Regeneron Articles

Biotech and Pharmaceutical Giants Go All In With Big Data Analytics

Friday’s Biggest Winners and Losers in the S&P 500

Will a PCSK9 Inhibitor Price Cut Help Drive Lowering LDL-Cholesterol Drug Use?

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Top Analyst Upgrades and Downgrades: Alcoa, Cemex, Comerica, Facebook, GM, Incyte, Proofpoint, Regeneron and More

10 Large Cap Stocks the Top Hedge Funds Are Buying Now

Top Analyst Upgrades and Downgrades: Capital One, Domino’s, Home Depot, Mosaic, Regenron, Six Flags, US Steel, Walmart and More

Top Analyst Upgrades and Downgrades: Amex, Cellectis, ForeScout, Mastercard, Mueller Water, PG&E, Party City, Regeneron, Visa and More

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

Top Analyst Upgrades and Downgrades: Baidu, Barclays, Celgene, HPE, Intel, Kimberly-Clark, Lululemon, PayPal, Stratasys and More

4 Red-Hot Merrill Lynch US 1 Momentum Stocks to Buy for the Rest of 2017

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

10 Top Stocks Analysts Want You to Sell Now

Top Analyst Upgrades & Downgrades: Boeing, Chipotle, First Solar, Goldman Sachs, IBM, Lockheed Martin, Lululemon, Vertex and Many More

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s